Geron
GERN
#6467
Rank
C$1.33 B
Marketcap
C$2.08
Share price
1.01%
Change (1 day)
11.44%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -C$48.98 Million

According to Geron's latest financial reports the company's current earnings are C$0.19 Billion. In 2025 the company made an earning of -C$70.89 Million, an increase over its 2024 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$48.98 Million-30.91%
2025 -C$70.89 Million-67.42%
2024 -C$0.22 Billion-11.23%
2023 -C$0.25 Billion30.22%
2022 -C$0.19 Billion20.15%
2021 -C$0.16 Billion50.08%
2020 -C$0.11 Billion4.46%
2019 -C$99.94 Million130.68%
2018 -C$43.33 Million8.84%
2017 -C$39.81 Million-3.08%
2016 -C$41.07 Million-22080.6%
2015 C$0.18 M-100.38%
2014 -C$49.62 Million-7.14%
2013 -C$53.43 Million
2011 -C$0.13 Billion19.04%
2010 -C$0.11 Billion8.45%
2009 -C$97.93 Million-2.51%
2008 -C$0.11 Billion14.65%
2007 -C$87.62 Million32.68%
2006 -C$66.03 Million25.59%
2005 -C$52.58 Million4.36%
2004 -C$50.38 Million19.73%
2003 -C$42.08 Million-15.46%
2002 -C$49.78 Million1.94%
2001 -C$48.83 Million33.59%
2000 -C$36.55 Million27.53%
1999 -C$28.66 Million63.13%
1998 -C$17.57 Million15.6%
1997 -C$15.2 Million-10.66%
1996 -C$17.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$14.95 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$2.47 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$96.54 Million 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.21 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$20.8 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA